sodium dodecylbenzenesulfonate
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2023 (NCT06224036)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetSurfactant
Surfactant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS554127163Y ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07170800 | Phase 2 | Sep 10, 2025 | Government of China |
| NCT06224036 | Phase 2 | Oct 31, 2023 | Capital Medical University, Huazhong University of Science and Technology, Sichuan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1